Volume 28; Issue 2

Cardiovascular Therapeutics

Volume 28; Issue 2

1

Statins Decrease Adverse Outcomes in Coronary Artery Bypass for Extensive Coronary Artery Disease as well as Left Main Coronary Stenosis

Hui-Li Gan, Jian-Qun Zhang, Ping Bo, Sheng-Xun Wang, Chun-Shang Lu

Journal:

Cardiovascular Therapeutics

Year:

2010

Language:

english

File:

PDF, 146 KB

english, 2010

2

What Should Medical Practitioners Know about the Role of Alternative Medicines in Cardiovascular Disease Management?

Thomas F. Whayne, Jr

Journal:

Cardiovascular Therapeutics

Year:

2010

Language:

english

File:

PDF, 207 KB

english, 2010

3

The Carvedilol's Beta-Blockade in Heart Failure and Exercise Training's Sympathetic Blockade in Healthy Athletes during the Rest and Peak Effort

Vitor Oliveira Carvalho, Edimar Alcides Bocchi, Guilherme Veiga Guimarães

Journal:

Cardiovascular Therapeutics

Year:

2010

Language:

english

File:

PDF, 182 KB

english, 2010

4

Insulin Signaling: A Possible Pathogenesis of Cardiac Hypertrophy

Wei Yu, Chunjuan Chen, Yucai Fu, Xin Wang, Wei Wang

Journal:

Cardiovascular Therapeutics

Year:

2010

Language:

english

File:

PDF, 125 KB

english, 2010

5

Preoperative Statin Therapy Decreases Risk of Postoperative Renal Insufficiency

Salim S. Virani, Vijay Nambi, Venkateshwar R. Polsani, Vei-Vei Lee, MacArthur Elayda, Shun Kohsaka, Wei Pan, Ross M. Reul, James M. Wilson, Laura A. Petersen, James T. Willerson, Christie M. Ballantyn

Journal:

Cardiovascular Therapeutics

Year:

2010

Language:

english

File:

PDF, 152 KB

english, 2010

6

Is Target Dose of Beta-Blocker More Important Than Achieved Heart Rate or Heart Rate Change in Patients with Systolic Chronic Heart Failure?

Pornwalee Porapakkham, Pramote Porapakkham, Henry Krum

Journal:

Cardiovascular Therapeutics

Year:

2010

Language:

english

File:

PDF, 133 KB

english, 2010

7

Statins—Is There Potential for Uncovering New Benefits (or Detriments)?

Michael Blazing

Journal:

Cardiovascular Therapeutics

Year:

2010

Language:

english

File:

PDF, 487 KB

english, 2010

8

Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials

Henry Krum, John J.V. McMurray, Edward Horton, Teresa Gerlock, Bjoern Holzhauer, Lineke Zuurman, Steven M. Haffner, M. Angelyn Bethel, Rury R. Holman, Robert M. Califf

Journal:

Cardiovascular Therapeutics

Year:

2010

Language:

english

File:

PDF, 126 KB

english, 2010